Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Eli Lilly and Company
National Cancer Institute (NCI)
NantCell, Inc.
National Cancer Institute (NCI)
University College, London
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Columbia University
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
University of Wisconsin, Madison
University of Pennsylvania
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Bayer
University of Kentucky
Massachusetts General Hospital
University of Washington
National Cancer Institute (NCI)
Sanofi
Columbia University
Federico II University
Yonsei University
National Cancer Institute (NCI)
Delcath Systems Inc.
Amgen
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eanm Research Ltd
Vanderbilt-Ingram Cancer Center
Assistance Publique - Hôpitaux de Paris